SIA
MEDP icon

Schear Investment Advisers’s Medpace MEDP Stock Holding History

Schear Investment Advisers’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.91M Buy
3,604
+502
+16% +$232K 0.64% 44
2026
Q1 		$1.49M Buy
+3,102
New +$1.59M 0.66% 47

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Schear Investment Advisers's MEDP Position: Q2 2026 in Review

Schear Investment Advisers increased its Medpace (MEDP) stake by 16% in Q2 2026, buying an estimated $232K and bringing the position to 3,604 shares worth $1.91M. The position accounts for 0.64% of the portfolio, ranked #44.

Schear Investment Advisers first reported a position in MEDP in Q1 2026 and has held it in 2 quarters since. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Schear Investment Advisers held 3,604 shares of Medpace worth $1.91M as of Q2 2026.
  • Schear Investment Advisers bought 502 Medpace shares in Q2 2026, an estimated $232K.
  • Medpace made up 0.64% of Schear Investment Advisers's portfolio in Q2 2026, its #44 holding.
  • Schear Investment Advisers first reported a position in Medpace in Q1 2026 and has held it in 2 quarters since.
  • 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Schear Investment Advisers's 13F filing for Q2 2026, filed 27 Jul 2026.